Hara Akira, Sakata Keiko, Yamada Yasuhiro, Kuno Toshiya, Kitaori Nami, Oyama Takeru, Hirose Yoshinobu, Murakami Akira, Tanaka Takuji, Mori Hideki
Department of Tumor Pathology, Graduate School of Medicine, Gifu University, 1-1 Yanagido, Gifu 501-1194, Japan.
Oncol Rep. 2005 Aug;14(2):345-51.
Alteration of beta-catenin expression in hepatocellular carcinomas (HCCs) may play an important role in tumor progression by stimulating cell proliferation. We have previously reported that auraptene (AUR), an antioxidant agent isolated from citrus fruit, effectively inhibits chemically induced hepatocarcinogenesis in rats. In this study, we investigated the molecular mechanism of the inhibitory effects of dietary supplementation with AUR on N,N-diethylnitrosamine (DEN)-initiated hepatocarcinogenesis. Male F344 rats initiated with DEN were fed the AUR-containing diet during either the initiation stage (initiation feeding for 7 weeks) or post-initiation phase (post-initiation feeding for 25 weeks) of hepatocarcinogenesis. Liver tumors >5 mm in diameter were used for the analysis of beta-catenin gene mutation and beta-catenin protein expression. After PCR amplification of exon 2 of the beta-catenin gene, the products were sequenced directly. Mutations in the beta-catenin gene were detected in 8 of 24 HCCs (33.3%) in the DEN alone group, 7 of 15 HCCs (46.7%) in the DEN + AUR (initiation feeding) group, and 0 of 8 HCCs (0%) in the DENright curved arrow AUR (post-initiation feeding) group. No mutations of beta-catenin gene were detected in liver cell adenomas of any group. These results demonstrate that AUR exposure in post-initiation period suppresses the occurrence of HCCs with beta-catenin mutation, presumably by negative selection for neoplastic cells harboring the mutation.
肝细胞癌(HCC)中β-连环蛋白表达的改变可能通过刺激细胞增殖在肿瘤进展中发挥重要作用。我们之前报道过,从柑橘类水果中分离出的抗氧化剂奥瑞烯(AUR)可有效抑制大鼠化学诱导的肝癌发生。在本研究中,我们调查了膳食补充AUR对N,N-二乙基亚硝胺(DEN)引发的肝癌发生的抑制作用的分子机制。用DEN启动的雄性F344大鼠在肝癌发生的起始阶段(起始喂养7周)或起始后阶段(起始后喂养25周)喂食含AUR的饮食。直径>5mm的肝肿瘤用于分析β-连环蛋白基因突变和β-连环蛋白蛋白表达。对β-连环蛋白基因的外显子2进行PCR扩增后,直接对产物进行测序。在仅DEN组的24个HCC中有8个(33.3%)检测到β-连环蛋白基因突变,在DEN + AUR(起始喂养)组的15个HCC中有7个(46.7%)检测到,在DEN→AUR(起始后喂养)组的8个HCC中未检测到(0%)。任何组的肝细胞腺瘤中均未检测到β-连环蛋白基因的突变。这些结果表明,起始后阶段暴露于AUR可抑制β-连环蛋白突变的HCC的发生,可能是通过对携带该突变的肿瘤细胞进行负选择实现的。